Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different 
        K-RAS Status.: Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

Yu Tang Chin; Zong Rong He; Chi Long Chen; Hsiao Ching Chu; Yih Ho; Po Yu Su; Yu Chen S.H. Yang; Kuan Wang; Ya Jung Shih; Yi Ru Chen; Jens Z. Pedersen; Sandra Incerpi; André Wendindondé Nana; Heng Yuan Tang; Hung Yun Lin; Shaker A. Mousa; Paul J. Davis; Jacqueline Whang-Peng

doi:10.3389/fendo.2019.00241

Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

Yu Tang Chin
, Zong Rong He
, Chi Long Chen
, Hsiao Ching Chu
, Yih Ho
, Po Yu Su
, Yu Chen S.H. Yang
, Kuan Wang
, Ya Jung Shih
, Yi Ru Chen
, Jens Z. Pedersen
, Sandra Incerpi
, André Wendindondé Nana
, Heng Yuan Tang
, Hung Yun Lin
, Shaker A. Mousa
, Paul J. Davis
, Jacqueline Whang-Peng

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	241
Pages (from-to)	241
Journal	Frontiers in Endocrinology
Volume	10
Issue number	APR
DOIs	https://doi.org/10.3389/fendo.2019.00241
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Anticancer
Colorectal cancer cells
Integrin αvβ3
NDAT
Perfusion bellows cell culture system
PhosphoERK1/2
Tetrac

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism

Access to Document

10.3389/fendo.2019.00241

Fingerprint

Dive into the research topics of 'Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)'. Together they form a unique fingerprint.

Cite this

Chin, Y. T., He, Z. R., Chen, C. L., Chu, H. C., Ho, Y., Su, P. Y., Yang, Y. C. S. H., Wang, K., Shih, Y. J., Chen, Y. R., Pedersen, J. Z., Incerpi, S., Nana, A. W., Tang, H. Y., Lin, H. Y., Mousa, S. A., Davis, P. J., & Whang-Peng, J. (2019). Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130). Frontiers in Endocrinology, 10(APR), 241. Article 241. https://doi.org/10.3389/fendo.2019.00241

Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130). / Chin, Yu Tang; He, Zong Rong; Chen, Chi Long et al.
In: Frontiers in Endocrinology, Vol. 10, No. APR, 241, 2019, p. 241.

Research output: Contribution to journal › Article › peer-review

Chin, YT, He, ZR, Chen, CL, Chu, HC, Ho, Y, Su, PY, Yang, YCSH , Wang, K, Shih, YJ, Chen, YR, Pedersen, JZ, Incerpi, S, Nana, AW, Tang, HY, Lin, HY, Mousa, SA, Davis, PJ & Whang-Peng, J 2019, 'Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)', Frontiers in Endocrinology, vol. 10, no. APR, 241, pp. 241. https://doi.org/10.3389/fendo.2019.00241

Chin YT, He ZR, Chen CL, Chu HC, Ho Y, Su PY et al. Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130). Frontiers in Endocrinology. 2019;10(APR):241. 241. doi: 10.3389/fendo.2019.00241

Chin, Yu Tang ; He, Zong Rong ; Chen, Chi Long et al. / Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130). In: Frontiers in Endocrinology. 2019 ; Vol. 10, No. APR. pp. 241.

@article{44accd234e2e48639f0a5782ffd478fb,

title = "Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status.: Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)",

abstract = "In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "Anticancer, Colorectal cancer cells, Integrin αvβ3, NDAT, Perfusion bellows cell culture system, PhosphoERK1/2, Tetrac",

author = "Chin, \{Yu Tang\} and He, \{Zong Rong\} and Chen, \{Chi Long\} and Chu, \{Hsiao Ching\} and Yih Ho and Su, \{Po Yu\} and Yang, \{Yu Chen S.H.\} and Kuan Wang and Shih, \{Ya Jung\} and Chen, \{Yi Ru\} and Pedersen, \{Jens Z.\} and Sandra Incerpi and Nana, \{Andr{\'e} Wendindond{\'e}\} and Tang, \{Heng Yuan\} and Lin, \{Hung Yun\} and Mousa, \{Shaker A.\} and Davis, \{Paul J.\} and Jacqueline Whang-Peng",

note = "Publisher Copyright: {\textcopyright} 2019 Chin, He, Chen, Chu, Ho, Su, Yang, Wang, Shih, Chen, Pedersen, Incerpi, Nana, Tang, Lin, Mousa, Davis and Whang-Peng.",

year = "2019",

doi = "10.3389/fendo.2019.00241",

language = "English",

volume = "10",

pages = "241",

journal = "Frontiers in Endocrinology",

issn = "1664-2392",

publisher = "Frontiers Media SA",

number = "APR",

}

TY - JOUR

T1 - Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status.

T2 - Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

AU - Chin, Yu Tang

AU - He, Zong Rong

AU - Chen, Chi Long

AU - Chu, Hsiao Ching

AU - Ho, Yih

AU - Su, Po Yu

AU - Yang, Yu Chen S.H.

AU - Wang, Kuan

AU - Shih, Ya Jung

AU - Chen, Yi Ru

AU - Pedersen, Jens Z.

AU - Incerpi, Sandra

AU - Nana, André Wendindondé

AU - Tang, Heng Yuan

AU - Lin, Hung Yun

AU - Mousa, Shaker A.

AU - Davis, Paul J.

AU - Whang-Peng, Jacqueline

PY - 2019

Y1 - 2019

N2 - In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

KW - Anticancer

KW - Colorectal cancer cells

KW - Integrin αvβ3

KW - NDAT

KW - Perfusion bellows cell culture system

KW - PhosphoERK1/2

KW - Tetrac

UR - https://www.scopus.com/pages/publications/85067693595

UR - https://www.scopus.com/pages/publications/85067693595#tab=citedBy

U2 - 10.3389/fendo.2019.00241

DO - 10.3389/fendo.2019.00241

M3 - Article

C2 - 31024461

AN - SCOPUS:85067693595

SN - 1664-2392

VL - 10

SP - 241

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

IS - APR

M1 - 241

ER -